KRT17 and cancer: In oral cancer cells, miR-485-5p suppresses keratin 17 (KRT17), which in turn represses the integrin β4/α6/FAK/Src/ERK/β-catenin pathway, impacting cancer progression and resistance to cisplatin and carboplatin [40].